University of Michigan Magazine covers story on UM Pharmacy Cancer Study - News Details

iRxReminder in the News

University of Michigan Magazine covers story on UM Pharmacy Cancer Study

University of Michigan Magazine covers story on UM Pharmacy Cancer Study
Feb 7, 2017, 12:00 am

Empowering Patients To Manage Their Own Meds Safely

2/7/2017
From: Nicole Panyard

Story is online here.

Dr. Anthony Sterns, a 1987 Naval Architecture and Marine Engineering alum and the founder and CEO of iRxReminder LLC, is leading a team developing the iRxCapture App and the iLidRx pill dispensing pod to work together so that patients and their healthcare team can monitor and manage medication taking together.

People are generally not very good at taking their medications as directed. In fact, the CDC (2015) reports that 700,000 ER visits, 341,000 hospitalizations, and 125,000 deaths are attributed each year to not taking medications correctly. This represents an estimated $320 billion in unnecessary healthcare expenses that can potentially be avoided. While there are many great medications, not taking the right amount of medication at the right time means not getting the medications benefits. For those at risk of not taking their medications, the iRxReminder platform is designed to ensure patients take critical medications successfully.

The pods are the result of a collaboration of iRxReminder founder and CEO, Dr. Anthony Sterns, and Kent State University Professor of Psychology Joel Hughes.

The iLidRx™ pod holds up to a 90-day supply of a single medication. The medication is dispensed by holding the pod like a computer mouse and touching the pad at the front. The user lifts and places the pod on the hand, tilts it sideways, and the pill is dispensed. The hold, place, and tilt™ method or gesture-based™ dispensing is one of the iLidRx pods many innovations.

Dr Shawna Kraft, a PharmD and clinical faculty member of the College of Pharmacy is the principal investigator for a study to improve the adherence of oral chemotherapy medications funded by the Hematology Oncology Association. The study is now underway at the University of Michigan Cancer Center. The research team includes Drs. Karen Farris and Mike Dorsch, also UMCOP faculty.

The development of the pod was funded by the National Institutes of Health, The Ohio Third Frontier Technology and Validation Start-up Fund, the GLIDE innovation Fund, The North Coast Opportunity Tech Fund, The MAGNET IMPAcT Fund, and the City of Cleveland Office of Economic Development, as well as angel investors. iRxReminder LLC is based in Cleveland, OH but has customers throughout North America.

“I’m elated to get the chance to come back to The University of Michigan and work with these outstanding collaborators. Having the opportunity to impact the delivery of life-saving medications to patients at this world-class facility is one of the highlights of my professional career. I’m honored to take this first step into the field with our technology at my alma mater. It’s truly exciting!” said Dr. Sterns.

He continues, “We created the app and iLidRx pod to serve as a cognitive prosthetic to empower patients to take control of the self-management of their treatment once they are away from the hospital and clinic. At the same time, the App provides feedback to the patient’s healthcare team so they know exactly how their patient is doing, their exact medication taking, and they can also receive any symptoms and side effects. It creates a framework to deliver care that is truly patient centered and gives information to the healthcare team whereas they would otherwise have to rely on the patient’s memory. When clinic visits are weeks or months apart, it’s not a reliable way to measure adherence, particularly when these medications are critical such as with oral chemotherapy.”

Article topics: Applications , Cancer Research , Health , Healthcare , Medical Devices , Safety , Alumni